lifestyle.capitolhilltimes.com

Author: CARIS MPI, INC., d/b/a CARIS LIFE SCIENCES

Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

November 11, 2025
Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response

October 31, 2025
Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025

October 24, 2025